An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up

OBJECTIVES: The aim was to investigate the long-term prophylactic efficacy, drug retention and safety of low-dose sulfamethoxazole–trimethoprim (SMX/TMP) prophylaxis against Pneumocystis pneumonia (PCP). METHODS: Adult patients with rheumatic diseases receiving prednisolone ≥0.6 mg/kg/day were rando...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Rheumatol Adv Pract
Autori principali: Utsunomiya, Masako, Dobashi, Hiroaki, Odani, Toshio, Saito, Kazuyoshi, Yokogawa, Naoto, Nagasaka, Kenji, Takenaka, Kenchi, Soejima, Makoto, Sugihara, Takahiko, Hagiyama, Hiroyuki, Hirata, Shinya, Matsui, Kazuo, Nonomura, Yoshinori, Kondo, Masahiro, Suzuki, Fumihito, Nawata, Yasushi, Tomita, Makoto, Kihara, Mari, Yokoyama-Kokuryo, Waka, Hirano, Fumio, Yamazaki, Hayato, Sakai, Ryoko, Nanki, Toshihiro, Koike, Ryuji, Miyasaka, Nobuyuki, Harigai, Masayoshi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Concise Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7585401/
https://ncbi.nlm.nih.gov/pubmed/33134810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa029
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi